Free Trial

908 Shares in Molina Healthcare, Inc. (NYSE:MOH) Acquired by Aptus Capital Advisors LLC

Molina Healthcare logo with Medical background

Aptus Capital Advisors LLC purchased a new stake in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 908 shares of the company's stock, valued at approximately $264,000.

Several other hedge funds have also added to or reduced their stakes in MOH. Norges Bank bought a new stake in shares of Molina Healthcare during the fourth quarter worth $134,675,000. FMR LLC grew its position in shares of Molina Healthcare by 31.1% during the 4th quarter. FMR LLC now owns 1,801,113 shares of the company's stock worth $524,214,000 after purchasing an additional 427,276 shares in the last quarter. Invesco Ltd. increased its holdings in Molina Healthcare by 28.5% in the 4th quarter. Invesco Ltd. now owns 1,327,021 shares of the company's stock valued at $386,229,000 after buying an additional 294,180 shares during the period. Wellington Management Group LLP raised its holdings in shares of Molina Healthcare by 7.4% during the 4th quarter. Wellington Management Group LLP now owns 2,632,232 shares of the company's stock worth $766,111,000 after buying an additional 181,073 shares in the last quarter. Finally, Los Angeles Capital Management LLC grew its position in Molina Healthcare by 166.1% during the 4th quarter. Los Angeles Capital Management LLC now owns 196,513 shares of the company's stock worth $57,195,000 after acquiring an additional 122,674 shares during the last quarter. Institutional investors own 98.50% of the company's stock.

Insider Activity

In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of the stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $301.33, for a total transaction of $301,330.00. Following the completion of the transaction, the director now owns 17,375 shares of the company's stock, valued at $5,235,608.75. This represents a 5.44% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Joseph M. Zubretsky sold 87,500 shares of the firm's stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total value of $28,005,250.00. Following the completion of the transaction, the chief executive officer now owns 257,715 shares in the company, valued at approximately $82,484,262.90. This trade represents a 25.35% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 89,169 shares of company stock worth $28,520,995 over the last 90 days. 1.10% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on MOH shares. Baird R W lowered Molina Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. StockNews.com raised shares of Molina Healthcare from a "hold" rating to a "buy" rating in a research report on Friday, April 11th. Sanford C. Bernstein initiated coverage on shares of Molina Healthcare in a report on Tuesday, April 22nd. They set an "outperform" rating and a $414.00 target price on the stock. Wells Fargo & Company raised Molina Healthcare from an "equal weight" rating to an "overweight" rating and lifted their price objective for the company from $295.00 to $372.00 in a research note on Wednesday, March 5th. Finally, Guggenheim assumed coverage on Molina Healthcare in a research report on Wednesday, April 9th. They issued a "neutral" rating for the company. Nine investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $365.38.

View Our Latest Stock Analysis on MOH

Molina Healthcare Stock Up 1.6%

Shares of NYSE MOH traded up $5.27 during mid-day trading on Monday, reaching $327.47. 631,630 shares of the company were exchanged, compared to its average volume of 682,177. Molina Healthcare, Inc. has a 1 year low of $262.32 and a 1 year high of $365.23. The stock has a market cap of $17.75 billion, a price-to-earnings ratio of 16.03, a P/E/G ratio of 1.06 and a beta of 0.63. The company has a quick ratio of 1.62, a current ratio of 1.62 and a debt-to-equity ratio of 0.69. The firm has a 50-day moving average of $325.04 and a 200 day moving average of $308.39.

Molina Healthcare (NYSE:MOH - Get Free Report) last issued its earnings results on Wednesday, April 23rd. The company reported $6.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.96 by $0.12. The firm had revenue of $11.15 billion during the quarter, compared to analysts' expectations of $10.86 billion. Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. The firm's revenue was up 12.2% compared to the same quarter last year. During the same quarter last year, the company posted $5.73 earnings per share. On average, research analysts expect that Molina Healthcare, Inc. will post 24.4 earnings per share for the current year.

Molina Healthcare Company Profile

(Free Report)

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Featured Articles

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Should You Invest $1,000 in Molina Healthcare Right Now?

Before you consider Molina Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.

While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 3 Insider Stock Buys in April—Are They Still Good in May?
5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines